Tender detail
Non-exclusive pharmaceutical discount agreement for allergen extract from timothy grass pollen only (V01AA02), 1 October 2026–31 October 2027
Summary
DAK-Gesundheit intends to conclude non-exclusive pharmaceutical discount agreements with as many interested pharmaceutical companies as possible for medicines containing allergen extract derived exclusively from timothy grass pollen (ATC V01AA02). The agreement is intended to run from 1 October 2026 to 31 October 2027, but will end automatically if an exclusive agreement for the same active substance enters into force earlier. The bidder must identify the relevant medicines in Annex 2 to the agreement. The submission deadline is 28 August 2027.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.